BRISTOL MYERS SQUIBB CO (BMY)
Pharmaceutical Preparations
Latest Price
$65.31
TTM P/E
18.29
Normalized P/E
34.74
Div Yield
3.83%
Book Value
9.85
P/B Ratio
6.63
Valuation metrics
adjust assumptions →EPS: $3.46
Book value / share: $9.06
Formula: √(22.5 × EPS × BVPS)
Graham Number
$26.56
59% downside
Norm. op. income: $8.9B (median of 7yr)
Tax rate: 18%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$18.07
72% downside
Base FCF: $12.8B (median of recent 5yr)
Growth: 8%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$116.60
+79% upside
EPS: $3.46
Target P/E: 35×
Formula: EPS × P/E
P/E Fair Value
$121.10
+85% upside
Institutional Ownership
72.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 171.68M | $10.41B | 8.42% | -5.14M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 132.32M | $8.03B | 6.49% | -- | 2026-03-31 |
| STATE STREET CORP | 98.56M | $5.98B | 4.84% | +584.5K | 2026-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 61.12M | $3.71B | 3.00% | -10.21M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 55.29M | $3.34B | 2.71% | +2.65M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 46.23M | $2.80B | 2.27% | -- | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 32.59M | $1.98B | 1.60% | +17.53M | 2026-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 29.63M | $1.80B | 1.45% | +3.83M | 2026-03-31 |
| MORGAN STANLEY | 29.20M | $1.77B | 1.43% | +849.9K | 2026-03-31 |
| AMERIPRISE FINANCIAL INC | 26.47M | $1.60B | 1.30% | -1.59M | 2026-03-31 |